| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |